2025 Latin America Anti-Infective Vaccines Market Revenue Opportunities Report
Description
The 2025 Latin America Anti-Infective Vaccines Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Anti-Infective Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Latin America anti-infective vaccines market are Sanofi Pasteur, GlaxoSmithKline (GSK), Pfizer Laboratories Ltd, and Novartis AG. Sanofi Pasteur, headquartered in France, is a key player supplying vaccines for influenza, polio, and yellow fever, strongly committed to immunization programs across the region. GlaxoSmithKline, with a significant presence, focuses on multiple infectious disease vaccines and collaborates with local health initiatives to improve vaccine access in Latin America. Pfizer, known for its strong vaccine portfolio including mRNA vaccines developed with BioNTech, plays a major role in COVID-19 vaccination efforts and other infectious disease prevention in Latin America. Novartis also participates in vaccine production and distribution throughout Latin America, leveraging its global resources to address regional public health needs.
In addition to these multinational corporations, local institutions like Brazil’s Butantan Institute significantly contribute to vaccine production and research, supporting regional immunization efforts and collaborations with international companies. The Latin America vaccine market, valued at USD 4.47 billion in 2024, is growing due to increased infectious disease prevalence and expanding healthcare infrastructure, boosting demand for anti-infective vaccines supplied primarily by these major companies. These players emphasize innovation, focusing on research and development to introduce newer vaccine technologies and expand immunization coverage across Latin American countries.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Anti-Infective Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Latin America anti-infective vaccines market are Sanofi Pasteur, GlaxoSmithKline (GSK), Pfizer Laboratories Ltd, and Novartis AG. Sanofi Pasteur, headquartered in France, is a key player supplying vaccines for influenza, polio, and yellow fever, strongly committed to immunization programs across the region. GlaxoSmithKline, with a significant presence, focuses on multiple infectious disease vaccines and collaborates with local health initiatives to improve vaccine access in Latin America. Pfizer, known for its strong vaccine portfolio including mRNA vaccines developed with BioNTech, plays a major role in COVID-19 vaccination efforts and other infectious disease prevention in Latin America. Novartis also participates in vaccine production and distribution throughout Latin America, leveraging its global resources to address regional public health needs.
In addition to these multinational corporations, local institutions like Brazil’s Butantan Institute significantly contribute to vaccine production and research, supporting regional immunization efforts and collaborations with international companies. The Latin America vaccine market, valued at USD 4.47 billion in 2024, is growing due to increased infectious disease prevalence and expanding healthcare infrastructure, boosting demand for anti-infective vaccines supplied primarily by these major companies. These players emphasize innovation, focusing on research and development to introduce newer vaccine technologies and expand immunization coverage across Latin American countries.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
